What is Inscopix?
Inscopix is a leader in the development of innovative tools for real-time mapping of neural activity within brain circuits. By providing objective, quantitative, and in-brain assays, the company enables researchers to gain unprecedented insights into disease mechanisms. Unlike traditional methods that rely heavily on animal behavior, Inscopix's technology offers a more accurate predictive model for clinical efficacy. This capability is instrumental for pharmaceutical partners and academic institutions seeking to screen drug candidates with higher precision. The company's market position is defined by its commitment to overcoming historic challenges in neuroscience, effectively transforming how the industry approaches the development of next-generation therapeutics for neurological conditions.
How much funding has Inscopix raised?
Inscopix has raised a total of $11M across 2 funding rounds:
Series A
$10M
Debt
$1M
Series A (2016): $10M with participation from Playground, Floodgate Fund, and AME Cloud Ventures
Debt (2020): $1M led by PPP
Key Investors in Inscopix
Playground
Playground Global invests in founders harnessing frontier technologies to build transformational businesses with multi-generational impact across life sciences and next-gen compute.
Floodgate Fund
Floodgate Fund is a venture capital firm that specializes in early stage investments, focusing on identifying and backing innovative companies that are considered pattern breakers in the tech industry.
AME Cloud Ventures
AME Cloud Ventures is a venture fund focusing on seed to later stage companies that build infrastructure and value chains around data, supporting technology-heavy firms that create unique data.
What's next for Inscopix?
With the recent strategic financing, Inscopix is well-positioned to scale its operations and deepen its impact on the global drug discovery landscape. The company is expected to focus on expanding its partner ecosystem and enhancing its data-driven platforms to support more complex therapeutic development pipelines. As the demand for reliable, high-fidelity neural data grows, Inscopix's ability to provide actionable insights will likely remain a critical component of the biotechnology sector's efforts to address unmet medical needs. Future growth will likely involve further integration of its technology into large-scale clinical research initiatives, solidifying its role as an essential infrastructure provider for the future of brain health.
See full Inscopix company page
